Rii Junryo
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 24, 2024
The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.Shinpei Saito, Keisuke Ando, Shinichi Sakamoto
|Feb 27, 2024
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.Shuhei Kamada, Shinichi Sakamoto, Ryo Kinoshita
|Jan 08, 2024
L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity.Junryo Rii, Shinichi Sakamoto, Atsushi Mizokami
|Dec 11, 2022
Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer.Haruki Baba, Shinichi Sakamoto, Xue Zhao
|May 29, 2021
Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.Junryo Rii, Shinichi Sakamoto, Masahiro Sugiura
|Jun 06, 2020
Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients.Junryo Rii, Shinichi Sakamoto, Yasutaka Yamada
Pageof 1
Frequent Collaborators
5 joint publications
Shinichi Sakamoto
5 joint publications
Yasutaka Yamada
3 joint publications
Yoshikatsu Kanai
1 joint publications
Toru Hirota
1 joint publications
Atsushi Kaneda
1 joint publications
Xue Zhao
1 joint publications
Naohiko Anzai
1 joint publications
Shuhei Kamada
1 joint publications
Atsushi Mizokami
